Northern Trust Corp Alnylam Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 734,919 shares of ALNY stock, worth $180 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

734,919

Previous 780,835 5.88%

Holding current value

$180 Million

Previous $190 Million 6.55%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $10.7 Million - $13.2 Million	-45,916 Reduced 5.88%	734,919 $202 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $5.91 Million - $10.2 Million	41,251 Added 5.58%	780,835 $190 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $3.65 Million - $4.94 Million	-24,936 Reduced 3.26%	739,584 $111 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $5.02 Million - $6.52 Million	-33,180 Reduced 4.16%	764,520 $146 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $4.31 Million - $5.34 Million	25,230 Added 3.27%	797,700 $141 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $2.01 Million - $2.31 Million	10,886 Added 1.43%	772,470 $147 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $2.2 Million - $2.84 Million	12,045 Added 1.61%	761,584 $153 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $2.88 Million - $3.75 Million	15,547 Added 2.12%	749,539 $178 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $408,000 - $683,240	-2,945 Reduced 0.4%	733,992 $147 Million
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $3.18 Million - $4.47 Million	-26,403 Reduced 3.46%	736,937 $107 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $772,364 - $1.06 Million	-6,073 Reduced 0.79%	763,340 $125 Million
Q4 2021 Feb 08, 2022	SELL	$159.56 - $209.29 $1.55 Million - $2.03 Million	-9,708 Reduced 1.25%	769,413 $130 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $12 Million - $14.7 Million	70,615 Added 9.97%	779,121 $147 Million
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $5.36 Million - $7.38 Million	-41,706 Reduced 5.56%	708,506 $120 Million
Q1 2021 May 12, 2021	BUY	$126.83 - $175.69 $943,868 - $1.31 Million	7,442 Added 1.0%	750,212 $106 Million
Q4 2020 Feb 11, 2021	SELL	$122.97 - $147.0 $1.18 Million - $1.42 Million	-9,628 Reduced 1.28%	742,770 $96.5 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $2.74 Million - $3.75 Million	-22,641 Reduced 2.92%	752,398 $110 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $8.23 Million - $12.3 Million	78,943 Added 11.34%	775,039 $115 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $2.71 Million - $3.9 Million	29,075 Added 4.36%	696,096 $75.8 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $35,988 - $60,003	483 Added 0.07%	667,021 $76.8 Million
Q3 2019 Nov 13, 2019	BUY	$70.9 - $87.82 $6.85 Million - $8.49 Million	96,655 Added 16.96%	666,538 $53.6 Million
Q2 2019 Aug 13, 2019	BUY	$65.86 - $92.79 $762,527 - $1.07 Million	11,578 Added 2.07%	569,883 $41.4 Million
Q1 2019 May 13, 2019	BUY	$72.76 - $93.45 $1.94 Million - $2.49 Million	26,657 Added 5.01%	558,305 $52.2 Million
Q4 2018 Feb 12, 2019	BUY	$62.67 - $88.33 $2.33 Million - $3.28 Million	37,136 Added 7.51%	531,648 $38.8 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $152,634 - $213,936	1,744 Added 0.35%	494,512 $43.3 Million
Q2 2018 Sep 18, 2018	SELL	$88.31 - $107.8 $554,586 - $676,984	-6,280 Reduced 1.26%	492,768 $48.5 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $2.41 Million - $2.94 Million	27,272 Added 5.78%	499,048 $49.2 Million
Q1 2018 May 09, 2018	SELL	$115.92 - $148.54 $328,401 - $420,813	-2,833 Reduced 0.6%	471,776 $56.2 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $11.2 Million - $13.7 Million	97,881 Added 25.98%	474,609 $60.3 Million
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $27.3 Million - $44.6 Million	376,728	376,728 $44.3 Million

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Alnylam Pharmaceuticals, Inc. Transaction History